Sarah London

Template:Infobox person

Sarah London (née McGinty; born 1979/1980) is an American business executive who has served as Chief Executive Officer of Centene Corporation, one of the largest healthcare companies in the United States, since March 2022. As of February 2024, she is the youngest CEO in the Fortune 500, leading a company with approximately $144 billion in annual revenue that provides healthcare coverage to over 27 million people, primarily through government-sponsored programs including Medicaid and Medicare.

London's career has been defined by her focus on health data, technology, and healthcare delivery transformation. Before joining Centene, she held leadership positions at UnitedHealth Group's Optum division, where she developed expertise in healthcare analytics and venture investing. Her appointment to lead Centene at a relatively young age represented a generational shift in leadership at one of America's largest healthcare companies.

Early life and education

Sarah London was born Sarah McGinty circa 1979-1980 and grew up in St. Louis, Missouri. Her father, John Edward McGinty, was an alumnus of the University of Chicago Booth School of Business, graduating in the class of 1970. He would later become a significant influence on his daughter's educational and career choices.

London attended Harvard College, where she earned her bachelor's degree magna cum laude in History and Literature. While at Harvard, she competed in Division I tennis, an experience that taught her lessons about competition, discipline, and teamwork that she would later apply to her business career.

Following her father's footsteps, London pursued her MBA at the University of Chicago Booth School of Business, graduating with High Honors. The connection between father and daughter came full circle when John McGinty attended Sarah's Booth graduation ceremony - 40 years to the day after his own graduation from the same institution.

Tragically, John McGinty died of cancer in 2011, just a few weeks before Sarah's wedding. The timing of this loss, coming so close to what should have been a joyful milestone, left a lasting impression on those who knew her. "She has had to work through some hard times, and she's handled it with such grace," observed colleagues. "It can be hard for CEOs to seem like they can relate, but to me, the way she handled her wedding so soon after her father's death was an example of her humanity."

Career

Early career

London's career has been centered on the intersection of healthcare, data, and technology. She began building expertise in healthcare analytics and technology before moving into venture capital and eventually operations.

UnitedHealth Group / Optum

London held several positions within UnitedHealth Group, America's largest health insurance company. She served as an Operating Partner at Optum Ventures, the venture capital arm of UnitedHealth, where she evaluated and invested in healthcare technology startups. Prior to the venture role, she served as Chief Product Officer for Optum Analytics, where she led strategy and commercialization for the company's integrated data solutions serving healthcare providers, payers, and life sciences companies.

Centene Corporation (2020-present)

London joined Centene in 2020 as Senior Vice President of Technology and Modernization, tasked with upgrading the company's technology infrastructure and digital capabilities. Her rapid rise through the organization drew attention - she was subsequently promoted to Vice Chairman, giving her broad oversight of the company's strategic direction.

CEO appointment

In March 2022, Centene announced that London would succeed Michael Neidorff as CEO. Neidorff, the company's founder and longtime leader, had built Centene from a small health plan into a healthcare giant over more than two decades. The transition drew some criticism from industry observers. Jefferies analyst David Windley characterized the succession planning as "anything but clean" and "puzzling," noting the relatively rapid timeline of London's ascent to the top role.

London's appointment came amid pressure from activist investors seeking changes to Centene's management and governance. The selection of a younger, technology-focused leader signaled a strategic pivot toward digital transformation and data-driven healthcare delivery.

Leadership and strategy

As CEO, London has emphasized technology investment, operational efficiency, and the company's core mission of serving vulnerable populations through government healthcare programs. Centene provides coverage to approximately 27 million members, predominantly through Medicaid managed care contracts with states, Medicare Advantage plans, and coverage through the Affordable Care Act insurance exchanges.

London made headlines early in her tenure by redirecting stadium naming rights funds toward community programs focused on health, sports, and education - a decision that earned recognition on Modern Healthcare's 2023 list of the 100 Most Influential People in Healthcare.

Personal life

London married Terry London in 2011, just weeks after her father's death from cancer. The couple has two sons together and resides in St. Louis, maintaining connections to the city where Centene is headquartered.

The circumstances of her wedding - proceeding with the celebration so soon after profound personal loss - have been cited by colleagues as evidence of her emotional resilience and ability to navigate difficult circumstances with grace.

Compensation

As CEO of Centene, London earned total compensation of $20.6 million in 2024, an 11% increase from her 2023 compensation of $18.6 million. Her 2024 pay package included:

Base salary: $1,400,000
Bonus: $4,289,125
Stock awards: $14,630,132
Other compensation: $282,891

Centene's disclosed CEO pay ratio indicated London earned 224 times the median employee's pay for fiscal year 2024, a figure that has drawn attention from labor advocacy groups and corporate governance watchdogs.

Controversies and challenges

Medicaid funding uncertainty

In April 2025, Centene's stock came under significant pressure amid market concerns over potential federal cuts to Medicaid funding. As a company heavily dependent on government healthcare contracts, particularly Medicaid managed care, policy changes at the federal or state level pose material risks to Centene's revenue and profitability.

State contracting issues

In May 2023, Tennessee announced it would rebid a $123 million contract that Centene's subsidiary Centurion Health had won to provide behavioral care in the state's prison system. A competing bidder, Corizon, filed a federal court complaint alleging that the CFO of Tennessee's Department of Corrections improperly communicated with Centurion during the bidding process. The state subsequently raised the requirement for a performance bond that Corizon could not meet, leading to allegations of an unfair bidding process.

Pharmacy benefit manager scrutiny

As a major player in Medicaid managed care, Centene operates pharmacy benefit managers (PBMs) that handle prescription drug coverage for state programs. PBMs have faced increasing scrutiny from policymakers and patient advocates who argue they contribute to high drug prices and create conflicts of interest in pharmaceutical pricing and distribution.

Succession planning criticism

Industry analysts questioned Centene's succession planning process, with the transition from founder Michael Neidorff to London characterized by some observers as hasty or insufficiently planned. The involvement of activist investors in pushing for leadership changes added complexity to what observers noted should have been a smoother transition.

Awards and recognition

Named to Modern Healthcare's 100 Most Influential People in Healthcare (2023)
Youngest CEO in the Fortune 500 (as of February 2024)
Fortune's Most Powerful Women list
Business Roundtable member

References